How much colonoscopy screening should be recommended to individuals with various degrees of family history of colorectal cancer?
MetadataShow full item record
BACKGROUND: Individuals with a family history of colorectal cancer (CRC) are at increased risk for CRC. Current screening recommendations for these individuals are based on expert opinion. The authors investigated optimal screening strategies for individuals with various degrees of family history of CRC based on a cost-effectiveness analysis. METHODS: The MISCAN-Colon microsimulation model was used to estimate costs and effects of CRC screening strategies, varying by the age at which screening was started and stopped and by screening interval. The authors defined 4 risk groups, characterized by the number of affected first-degree relatives and their age at CRC diagnosis. For all risk groups, the optimal screening strategy had an incremental cost-effectiveness ratio of approximately $50,000 per life-year gained. RESULTS: The optimal screening strategy for individuals with 1 first-degree relative diagnosed after age 50 years was 6 colonoscopies every 5 years starting at age 50 years, compared with 4 colonoscopies every 7 years starting at age 50 years for average risk individuals. The optimal strategy had 10 colonoscopies every 4 years for individuals with 1 first-degree relative diagnosed before age 50 years, 13 colonoscopies every 3 years for individuals with 2 or more first-degree relatives diagnosed after age 50 years, and 15 colonoscopies every 3 years for individuals with 2 or more first-degree relatives of whom at least 1 was diagnosed before age 50 years. CONCLUSIONS: The optimal screening strategy varies considerably with the number of affected first-degree relatives and their age of diagnosis. Shorter screening intervals than the currently recommended 5 years may be appropriate for the highest risk individuals. © 2011 American Cancer Society.
Showing items related by title, author, creator and subject.
Goede, S.; Rabeneck, L.; Lansdorp_Vogelaar, Iris; Zauber, A.; Paszat, L.; Hoch, J.; Yong, J.; van Hees, F.; Tinmouth, J.; van Ballegooijen, M. (2015)In the province-wide colorectal cancer (CRC) screening program in Ontario, Canada, individuals with a family history of CRC are offered colonoscopy screening and those without are offered guaiac fecal occult blood testing ...
Estimation of benefits, burden, and harms of colorectal cancer screening strategies: Modeling study for the US preventive services Task ForceKnudsen, A.; Zauber, A.; Rutter, C.; Naber, S.; Doria-Rose, V.; Pabiniak, C.; Johanson, C.; Fischer, S.; Lansdorp_Vogelaar, Iris; Kuntz, K. (2016)Importance: The US Preventive Services Task Force (USPSTF) is updating its 2008 colorectal cancer (CRC) screening recommendations. Objective: To inform the USPSTF by modeling the benefits, burden, and harms of CRC screening ...
Wilschut, J.; Habbema, J.; Van Leerdam, M.; Hol, L.; Lansdorp_Vogelaar, Iris; Kuipers, E.; Van Ballegooijen, M. (2011)Background Fecal occult blood testing (FOBT) can be adapted to a limited colonoscopy capacity by narrowing the age range or extending the screening interval, by using a more specific test or hemoglobin cutoff level for ...